Know which small-cap and mid-cap stocks staged smart recovery from days low!
Know which small-cap and mid-cap stocks staged smart recovery from days low!

Know which small-cap and mid-cap stocks staged smart recovery from days low!

Recovery from the lower levels indicates that the market participants actively participated in these stocks at the lower levels.     

Karan Dsij Article rating: 3.9

Given the fact that the market made a strong recovery from the lower levels, it would be interesting to know which stocks have witnessed recovery from the day’s low.

Overnight Digest: These small caps will be in focus on Tuesday
Overnight Digest: These small caps will be in focus on Tuesday

Overnight Digest: These small caps will be in focus on Tuesday

Dhunseri Investments, Tata Teleservices (Maharashtra), Sastasundar Ventures, 3i Infotech, Digjam Limited, Jindal Photo Limited and Pansari Developers made a fresh 52-week high today.

Armaan Madhani Article rating: 3.6

On Monday, frontline indices Nifty 50 and Sensex corrected by 1.82 per cent each to close at 17,441 and 58,543.79 respectively. Nifty IT index fell by 474.60 points i.e. 1.32 per cent. BSE Smallcap index underperformed broader markets, descending 2.83 per cent.  

Nifty falls nearly 1,200 points from October 19 highs; UltraTech Cement and Grasim top gainers list, Coal India and IndusInd Bank among top losers!
Nifty falls nearly 1,200 points from October 19 highs; UltraTech Cement and Grasim top gainers list, Coal India and IndusInd Bank among top losers!

Nifty falls nearly 1,200 points from October 19 highs; UltraTech Cement and Grasim top gainers list, Coal India and IndusInd Bank among top losers!

Here is the complete list of Nifty 50 stocks performance since October 19, 2021

Karan Dsij Article rating: 4.6

All hopes were dashed in the initial hour of the trading itself as markets fell like a house of cards. The fall was so severe that Nifty witnessed one of the biggest single-day falls in the near term.

Laurus Labs acquires a small stake in cell and gene therapy company - ImmunoACT
Laurus Labs acquires a small stake in cell and gene therapy company - ImmunoACT

Laurus Labs acquires a small stake in cell and gene therapy company - ImmunoACT

In India, CAR-T therapy is not available and this collaboration will help them in bringing this novel technology to Indian patients at very affordable pricing.

Subramanian K Article rating: 3.7

Laurus Labs has signed an investment agreement with Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an advanced cell and gene therapy company to acquire a 26.62 per cent stake (fully diluted basis) for a cash consideration of approximately Rs 46 crore, subject to the fulfilment of certain conditions. 

Stock watch: Is BSE Limited all set to zoom?
Stock watch: Is BSE Limited all set to zoom?

Stock watch: Is BSE Limited all set to zoom?

Post consolidating for 16 weeks in an ascending triangle chart pattern, BSE Limited on weekly charts gave breakout with increased volumes. Read on to find out more.

Henil Shah Article rating: 4.0

Post consolidating for 16 weeks in an ascending triangle chart pattern, BSE Limited on weekly charts gave breakout with increased volumes. Read on to find out more.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The 52-week high refers to the highest market price of a given security over a 52-week (one year) period.

Avalokita Pandey Article rating: 3.8

Here’s a list of the stocks that are close to their 52-week high.

RSS
First19931994199519961998200020012002Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR